PATRICK FRIEDLI: Open Payments
NPI 1255341046 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 24 payments from 13 companies in 2025. Trend: 2023 $750 · 2024 $636 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $172 |
| PFIZER INC. | 3 | $156 |
| ABBVIE INC. | 4 | $90 |
| Verona Pharma, Inc. | 2 | $42 |
| Amgen Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Novo Nordisk Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: BREZTRI, NURTEC ODT, QULIPTA, Ohtuvayre, ELIQUIS, SPRAVATO, AIRSUPRA, Wegovy.
Industry payments across MI — which companies pay providers there.
